My watch list  


Systematic (IUPAC) name
(-)-2(S)-Benzyl-4-(cis-perhydroisoindol-2-yl)butyric acid
CAS number 207844-01-7
ATC code A10BX
PubChem 121891
Chemical data
Formula C19H25NO3 
Mol. mass 315.41 g/mol
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life  ?
Excretion  ?
Therapeutic considerations
Pregnancy cat.


Legal status
Routes oral

Mitiglinide (trade name Glufast®) is a drug for the treatment of type 2 diabetes.

Mitiglinide belongs to the meglitinide class of blood glucose-lowering drugs and is currently co-marketed in Japan by Kissei and Takeda. The North America rights to mitiglinide are held by Elixir Pharmaceuticals. Mitiglinide has not yet gained FDA approval.


Mitiglinide is thought to stimulate insulin secretion by closing the ATP-sensitive K(+) (K(ATP)) channels in pancreatic beta-cells


Mitiglinide is delivered in tablet form.

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Mitiglinide". A list of authors is available in Wikipedia.
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE